Protein misfolding and aggregation in cataract disease and prospects for prevention
The first ingredient, tirzepatide , is a dual GIP/GLP-1 receptor agonist originally developed by Eli Lilly and approved by the FDA under the brand names Mounjaro (for type 2 diabetes) and Zepbound (for chronic weight management)
Duration of Study: Short-term acute studies (e.g., 24-48 hours) will naturally have a different 5-Amino-1MQ dosage profile than long-term chronic studies (e.g., 4-12 weeks)
Saffron increased several short-chain-fatty-acidproducing genera and the researchers noted some correlations between microbiota changes and sleep parameters, but the study was too preliminary to allow clear conclusions about the extent to which saffrons effects on sleep are mediated by changes in the gut microbiota
Dissertation, Universitt Rostock
Friedman discussed the updated situation for compounded GLP-1s at his most recent GoodHormoneHealth Webinar on Sunday March 23, 2025 at 6:00 PM after his talk on How can Blue Zones and Maimonides principles be applied to lead a healthy life for patients with endocrine problems? It is available on YouTube at or or Protect access to compounded medications make your voice heard
